In scanning the list of holdings, I see such things as an emerging-market debt fund, Pfizer ( PFE), PetroChina ( PTR) and Nationwide Health Properties ( NHP). This is a very diverse mix indeed. CVY's price-to-earnings ratio is 11.13, compared to 14.71 for DVY; its price-to-book of 1.68 is also lower than DVY's 2.62. I might take this data with a grain or two of salt because of some of the unusual holdings in CVY. In addition, the betas are very similar: 0.87 for CVY and 0.85 for DVY. Finally, according to the Claymore literature, CVY's standard deviation (also a measure of volatility, where a lower number indicates less volatility) of 12.52 is slightly lower than DVY's 12.72. For investors willing to include a dividend ETF in their large-cap allocation as a way of introducing yield, this fund has the potential of being a better mousetrap. I would not, however, buy the Yield Hog just yet. In general, I like to give something a few months of trading to get a feel for what it will do on a day-to-day basis. At a minimum, this fund merits serious consideration.